Literature DB >> 20084466

Cocainomics: new insights into the molecular basis of cocaine addiction.

Scott E Hemby1.   

Abstract

Until recently, knowledge of the impact of abused drugs on gene and protein expression in the brain was limited to less than 100 targets. With the advent of high-throughput genomic and proteomic techniques, investigators are now able to evaluate changes across the entire genome and across thousands of proteins in defined brain regions and generate expression profiles of vulnerable neuroanatomical substrates in rodent and nonhuman primate drug abuse models and in human post-mortem brain tissue from drug abuse victims. The availability of gene and protein expression profiles will continue to expand our understanding of the short- and long-term consequences of drug addiction and other addictive disorders and may provide new approaches or new targets for pharmacotherapeutic intervention. This review summarizes several important genomic and proteomic studies of cocaine abuse/addiction from rodent, nonhuman primate, and human postmortem studies of cocaine abuse and explores how these studies have advanced our understanding of addiction.

Entities:  

Mesh:

Year:  2010        PMID: 20084466      PMCID: PMC3255087          DOI: 10.1007/s11481-009-9189-8

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  113 in total

Review 1.  The role of the striatopallidal and extended amygdala systems in drug addiction.

Authors:  G F Koob
Journal:  Ann N Y Acad Sci       Date:  1999-06-29       Impact factor: 5.691

2.  Repeated cocaine administration alters the expression of genes in corticolimbic circuitry after a 3-week withdrawal: a DNA macroarray study.

Authors:  Shigenobu Toda; Jacqueline F McGinty; Peter W Kalivas
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

Review 3.  Microarray studies of psychostimulant-induced changes in gene expression.

Authors:  Vadim Yuferov; David Nielsen; Eduardo Butelman; Mary Jeanne Kreek
Journal:  Addict Biol       Date:  2005-03       Impact factor: 4.280

4.  Regulation of cocaine reward by CREB.

Authors:  W A Carlezon; J Thome; V G Olson; S B Lane-Ladd; E S Brodkin; N Hiroi; R S Duman; R L Neve; E J Nestler
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

Review 5.  Assessment of genome and proteome profiles in cocaine abuse.

Authors:  Scott E Hemby
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

6.  PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine.

Authors:  J Douglass; A A McKinzie; P Couceyro
Journal:  J Neurosci       Date:  1995-03       Impact factor: 6.167

7.  Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments.

Authors:  B T Hope; H E Nye; M B Kelz; D W Self; M J Iadarola; Y Nakabeppu; R S Duman; E J Nestler
Journal:  Neuron       Date:  1994-11       Impact factor: 17.173

8.  Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5.

Authors:  J A Bibb; J Chen; J R Taylor; P Svenningsson; A Nishi; G L Snyder; Z Yan; Z K Sagawa; C C Ouimet; A C Nairn; E J Nestler; P Greengard
Journal:  Nature       Date:  2001-03-15       Impact factor: 49.962

9.  Cocaine use increases [3H]WIN 35428 binding sites in human striatum.

Authors:  K Y Little; J A Kirkman; F I Carroll; T B Clark; G E Duncan
Journal:  Brain Res       Date:  1993-11-19       Impact factor: 3.252

10.  Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens.

Authors:  M J Miserendino; E J Nestler
Journal:  Brain Res       Date:  1995-03-20       Impact factor: 3.252

View more
  6 in total

1.  AKAP signaling in reinstated cocaine seeking revealed by iTRAQ proteomic analysis.

Authors:  Kathryn J Reissner; Joachim D Uys; John H Schwacke; Susanna Comte-Walters; Jennifer L Rutherford-Bethard; Thomas E Dunn; Joe B Blumer; Kevin L Schey; Peter W Kalivas
Journal:  J Neurosci       Date:  2011-04-13       Impact factor: 6.167

Review 2.  Proteomic approaches and identification of novel therapeutic targets for alcoholism.

Authors:  Giorgio Gorini; R Adron Harris; R Dayne Mayfield
Journal:  Neuropsychopharmacology       Date:  2013-07-31       Impact factor: 7.853

Review 3.  Proteomic analyses of PKA and AKAP signaling in cocaine addiction.

Authors:  Kathryn J Reissner
Journal:  Neuropsychopharmacology       Date:  2013-01       Impact factor: 7.853

Review 4.  Genes and pathways co-associated with the exposure to multiple drugs of abuse, including alcohol, amphetamine/methamphetamine, cocaine, marijuana, morphine, and/or nicotine: a review of proteomics analyses.

Authors:  Ju Wang; Wenji Yuan; Ming D Li
Journal:  Mol Neurobiol       Date:  2011-09-16       Impact factor: 5.590

Review 5.  Biomarkers for the development of new medications for cocaine dependence.

Authors:  Kristopher J Bough; Shashi Amur; Guifang Lao; Scott E Hemby; Nilesh S Tannu; Kyle M Kampman; Joy M Schmitz; Diana Martinez; Kalpana M Merchant; Charles Green; Jyoti Sharma; Anne H Dougherty; F Gerard Moeller
Journal:  Neuropsychopharmacology       Date:  2013-08-27       Impact factor: 7.853

6.  Serum proteomic analysis reveals high frequency of haptoglobin deficiency and elevated thyroxine level in heroin addicts.

Authors:  Bing-Ying Zhou; Shi-Yan Yan; Wan-Lu Shi; Zhi Qu; Xin Zhao; Zhi-Min Liu; Xiao-Ping Pu
Journal:  PLoS One       Date:  2014-04-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.